Page last updated: 2024-10-18

dihydroxyacetone and Porphyrias

dihydroxyacetone has been researched along with Porphyrias in 1 studies

Porphyrias: A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson, JA1

Other Studies

1 other study available for dihydroxyacetone and Porphyrias

ArticleYear
Dihydroxyacetone for protection against long wavelength UVA radiation and blue light.
    The British journal of dermatology, 1992, Volume: 126, Issue:1

    Topics: Dihydroxyacetone; Humans; Photosensitivity Disorders; Porphyrias; Sunscreening Agents

1992